Under this scenario, we found that AML pretreatment with VEN followed by WT1-CTL co-culture led to increased AML cell death in OCI-AML2 and OCI-AML3 cells with additive efficacy (Fig. 4A, Supplementary Fig. 3A). Here, RUNX3 is linked to acute myeloid leukemia.